Robbins Arroyo LLP: Combination of IMS Health Holdings, Inc. (IMS) with Quintiles Transnational Holdings Inc. (Q) May Not Be ...
May 03 2016 - 3:15PM
Business Wire
Shareholder rights attorneys at Robbins Arroyo LLP are
investigating the proposed combination of IMS Health Holdings, Inc.
(NYSE: IMS) with Quintiles Transnational Holdings Inc. (NYSE: Q).
On May 3, 2016, the two companies announced the signing of a
definitive merger agreement pursuant to which Quintiles will merge
with IMS in an all-stock merger of equals transaction. Under the
terms of the agreement, IMS shareholders will receive 0.384 shares
of Quintiles for each share of IMS they own, the value of which is
equivalent to $26.53 per share of IMS.
View this information on the law firm's Shareholder Rights Blog:
www.robbinsarroyo.com/shareholders-rights-blog/ims-health-holdings-inc
Is the Proposed Acquisition Best for IMS and Its
Shareholders?
Robbins Arroyo LLP's investigation focuses on whether the board
of directors at IMS is undertaking a fair process to obtain maximum
value and adequately compensate its shareholders.
As an initial matter, the $26.53 merger consideration represents
a premium of only 0.1% based on IMS' average one-month closing
price. This premium is significantly below the average one-month
premium of nearly 38.44% for comparable transactions within the
past year. Further, the $26.53 merger consideration is
significantly below the target price of eight analysts ranging from
$32.00 set by an analyst at Piper Jaffray on March 24, 2016, to
$27.00 set by an analyst at Mizuho Securities USA Inc. on February
3, 2016. In the last three years, IMS traded as high as $33.52 on
July 31, 2015, and most recently traded above the merger
consideration – at $27.00 – on May 2, 2016.
On May 3, 2016, IMS reported strong earnings results for its
first quarter 2016. Revenue for the quarter was $774 million, an
increase of 22.5% compared to the same period last year. Operating
income for the quarter was $113 million, an increase of 24.2%
compared to the same period last year. Additionally, IMS has beat
consensus analyst estimates for adjusted EPS and adjusted net
income every quarter for the past two years, and has beat consensus
analyst estimates for revenue in three out of the past four
quarters. In commenting on these results, IMS Chairman and Chief
Executive Officer Ari Bousbib remarked, "We are pleased to report
another quarter of consistent strong operating performance, with
technology services revenue again growing double digits in our core
IMS business. Continued investment and new contract wins during the
quarter position us well to continue this momentum."
In light of these facts, Robbins Arroyo LLP is examining IMS's
board of directors' decision to sell the company now rather than
allow shareholders to continue to participate in the company's
continued success and future growth prospects.
IMS shareholders have the option to file a class action lawsuit
to ensure the board of directors obtains the best possible price
for shareholders and the disclosure of material information. IMS
shareholders interested in information about their rights and
potential remedies can contact attorney Darnell R. Donahue at (800)
350-6003, ddonahue@robbinsarroyo.com, or via the shareholder
information form on the firm's website.
Robbins Arroyo LLP is a nationally recognized leader in
securities litigation and shareholder rights law. The law firm
represents individual and institutional investors in shareholder
derivative and securities class action lawsuits, and has helped its
clients realize more than $1 billion of value for themselves and
the companies in which they have invested.
Attorney Advertising. Past results do not guarantee a similar
outcome.
View source
version on businesswire.com: http://www.businesswire.com/news/home/20160503006951/en/
Robbins Arroyo LLPDarnell R. Donahue(619) 525-3990 or Toll Free
(800) 350-6003ddonahue@robbinsarroyo.comwww.robbinsarroyo.com
IMS HEALTH HOLDINGS, INC. (NYSE:IMS)
Historical Stock Chart
From Jun 2024 to Jul 2024
IMS HEALTH HOLDINGS, INC. (NYSE:IMS)
Historical Stock Chart
From Jul 2023 to Jul 2024